Landscapes / Companies
Apsen Farmaceutica S.A. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
2
in active trials · 7 in all
Trials
2 active
12 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | 2 Aug 2029Phase 3 trial completes | |||
| Next date | 2 Aug 2029 · Phase 3 trial completes | ||||
| Also tested for | Alopecia, Androgenetic | ||||
| Open drug page | |||||
— |
Phase 2 | Dec 2027Phase 2 trial completes | |||
| Next date | Dec 2027 · Phase 2 trial completes | ||||
| Also tested for | Insomnia, Insomnia Chronic | ||||
| Open drug page | |||||
About
- No active trial
- APSCTC, APSLXR, Azythromycin, Dexibuprofen, Naftopidil
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021